Professor of Oncology and Pharmacology at Wayne State University School of Medicine.  Chief of Hematology and Oncology and also the head of the Gastrointestinal and Neuroendocrine cancers at the Henry Ford Cancer Institute in Detroit. Additionally, he is co-leader of the Pancreas Cancer Program.  He chairs the GI Committee at SWOG national group. Dr. Philip earned his medical degree at the University of Baghdad College of Medicine in Iraq and his Ph.D. in Clinical Pharmacology and Pharmacogenetics at the University of London Guy’s Hospital Medical School in the United Kingdom. He completed a fellowship in Medical Oncology in  Oxford/UK and the M.D. Anderson Cancer Center in Houston. He is board certified in Medical Oncology in the United States and a Fellow of the Royal College of Physicians in the UK. His major research interests are in the development of new therapies for gastrointestinal cancers with particular emphasis on pancreatic cancer.  He authored more than 300 manuscripts, review articles and editorials and co-edited a book on pancreatic cancer and another on gastrointestinal  cancers. Dr Philip is a member of the scientific board of the Pancreatic Action Network (PanCan), scientific board of Skyfoundation, and the Michigan Society of Hematology and Oncology board.